CD133/1 Antibody, anti-human, Vio® Bright B515 130-113-112 from Miltenyi Biotec

Product Specs
ItemCD133/1 Antibody, anti-human, Vio® Bright B515
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-113-112
Quantity100 tests in 200 µL
ApplicationsFlow cytometry
Conjugate/TagVio Bright B515
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman
IsotypeIgG1
CloneAC133
Hostmouse
Antibody TypePrimary antibodies
Clonalitymonoclonal
Concentration1:50
NCBI Full Gene Nameprominin 1
NCBI Gene AliasesAC133, CD133, CORD12, MCDR2, MSTP061, PROML1, RP41, STGD4
TargetCD133/1
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Slug overexpression induces stemness and promotes hepatocellular carcinoma cell invasion and metastasisOncology lettersJune 1, 2014Sun Y, Song GD, Sun N, Chen JQ, Yang SS.

(2) Stem cell niches in glioblastoma: a neuropathological viewBioMed research internationalJanuary 1, 2014Schiffer D, Mellai M, Annovazzi L, Caldera V, Piazzi A, Denysenko T, Melcarne A.

(3) Single-cell clones of liver cancer stem cells have the potential of differentiating into different types of tumor cellsCell death & diseaseOctober 17, 2013Liu H, Zhang W, Jia Y, Yu Q, Grau GE, Peng L, Ran Y, Yang Z, Deng H, Lou J.

(4) Role of asymmetric methylarginine and connexin 43 in the regulation of pulmonary endothelial functionPulmonary circulationSeptember 1, 2013Tsang H, Leiper J, Hou Lao K, Dowsett L, Delahaye MW, Barnes G, Wharton J, Howard L, Iannone L, Lang NN, et al.

(5) An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastomaCell reportsMay 30, 2013Rheinbay E, Suvà ML, Gillespie SM, Wakimoto H, Patel AP, Shahid M, Oksuz O, Rabkin SD, Martuza RL, Rivera MN, et al.

(6) Postnatal neural precursor cell regions in the rostral subventricular zone, hippocampal subgranular zone and cerebellum of the dog (Canis lupus familiaris)Histochemistry and cell biologyMarch 1, 2013Walton RM, Parmentier T, Wolfe JH.

(7) Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheresCancer biology & therapyFebruary 1, 2013Czyz M, Koprowska K, Sztiller-Sikorska M.

(8) Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cellsCytometry. Part A : the journal of the International Society for Analytical CytologyJanuary 1, 2013Park TS, Zimmerlin L, Zambidis ET.

(9) Tumor-specific chromosome mis-segregation controls cancer plasticity by maintaining tumor heterogeneityPloS oneJanuary 1, 2013Hu Y, Ru N, Xiao H, Chaturbedi A, Hoa NT, Tian XJ, Zhang H, Ke C, Yan F, Nelson J, et al.

(10) AQP9 expression in glioblastoma multiforme tumors is limited to a small population of astrocytic cells and CD15(+)/CalB(+) leukocytesPloS oneJanuary 1, 2013Jelen S, Parm Ulhøi B, Larsen A, Frøkiær J, Nielsen S, Rützler M.

(11) The effect of Heparin-VEGF multilayer on the biocompatibility of decellularized aortic valve with platelet and endothelial progenitor cellsPloS oneJanuary 1, 2013Ye X, Wang H, Zhou J, Li H, Liu J, Wang Z, Chen A, Zhao Q.

(12) Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomyBritish journal of cancerOctober 23, 2012Wong CK, Namdarian B, Chua J, Chin X, Speirs R, Nguyen T, Fankhauser M, Pedersen J, Costello AJ, Corcoran NM, et al.

(13) Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibitionNeoplasia (New York, N.Y.)May 1, 2012Clark PA, Iida M, Treisman DM, Kalluri H, Ezhilan S, Zorniak M, Wheeler DL, Kuo JS.

(14) Dental pulp stem cells differentiation reveals new insights in Oct4A dynamicsPloS oneJanuary 1, 2012Ferro F, Spelat R, D'Aurizio F, Puppato E, Pandolfi M, Beltrami AP, Cesselli D, Falini G, Beltrami CA, Curcio F.

(15) Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model systemPloS oneJanuary 1, 2012Fredebohm J, Boettcher M, Eisen C, Gaida MM, Heller A, Keleg S, Tost J, Greulich-Bode KM, Hotz-Wagenblatt A, Lathrop M, et al.

(16) Inhaled NO contributes to lung repair in piglets with acute respiratory distress syndrome via increasing circulating endothelial progenitor cellsPloS oneJanuary 1, 2012Qi Y, Qian L, Sun B, Liu L, Wu P, Sun L.

(17) CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitopeThe Journal of biological chemistryNovember 25, 2011Mak AB, Blakely KM, Williams RA, Penttilä PA, Shukalyuk AI, Osman KT, Kasimer D, Ketela T, Moffat J.

(18) Two Domains of Vimentin Are Expressed on the Surface of Lymph Node, Bone and Brain Metastatic Prostate Cancer Lines along with the Putative Stem Cell Marker Proteins CD44 and CD133CancersJuly 13, 2011Steinmetz NF, Maurer J, Sheng H, Bensussan A, Maricic I, Kumar V, Braciak TA.

(19) Expression of the stem cell markers nestin and CD133 on circulating melanoma cellsThe Journal of investigative dermatologyFebruary 1, 2011Fusi A, Reichelt U, Busse A, Ochsenreither S, Rietz A, Maisel M, Keilholz U.

(20) Polarization and migration of hematopoietic stem and progenitor cells rely on the RhoA/ROCK I pathway and an active reorganization of the microtubule networkThe Journal of biological chemistryOctober 8, 2010Fonseca AV, Freund D, Bornhäuser M, Corbeil D.

Be the First to Write a Review!

CD133/1 Antibody, anti-human, Vio® Bright B515 from Miltenyi Biotec

Miltenyi Biotec

Miltenyi Biotec

Citations (46)

Reviews

CD133/1 Antibody, anti-human, Vio® Bright B515 from Miltenyi Biotec

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map